-
CompareTheraPEAK™ X-VIVO™-15 Serum-free Hematopoietic Cell MediumCatalog #: BE08-879HTheraPEAK™X-VIVO™ 15, Serum-free hematopoietic cell medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 5L bagSales unit: each
-
CompareTheraPEAK™ X-VIVO™-15 Serum-free Hematopoietic Cell MediumCatalog #: BEBP02-061Q
TheraPEAKTMX-VIVOTM 15, Serum-free hematopoietic cell medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 1 L
Sales unit: each -
CompareHuman Peripheral Blood CD4+ T Cells, Cryopreserved, 10 MillionCatalog #: 2W-200
Cryopreserved ampule of Human Peripheral Blood CD4+ T Cells containing ≥10 million cells, negatively selected.
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Sales unit: each -
CompareHuman Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 50 millionCatalog #: CC-2702
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Sales unit: each -
CompareHuman Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 50 million, w/population frequencyCatalog #: CC-2702P
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cells with population frequency information
Sales unit: each -
CompareHuman Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 100 million, with cell type frequencyCatalog #: CC-2703P
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells with cell type frequency information
Sales unit: each -
CompareHuman Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 100 millionCatalog #: CC-2703
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Sales unit: Ampule -
CompareHuman Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 25 millionCatalog #: CC-2705
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 25 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Sales unit: Ampule -
CompareHuman Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 10 millionCatalog #: CC-2704
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 10 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Sales unit: Ampule -
CompareX-VIVOTM 15 Serum-free Hematopoietic Cell MediumCatalog #: 02-053QX-VIVO™ 15, with L-Glutamine, gentamicin, recombinant transferrin, and phenol red, xenofree, 1 LSales unit: each
-
Natural Killer Cells InfographicNatural Killer cells have an innate ability to recognize and destroy non-self cells.
-
3D Natural Killer Cell-mediated Cytotoxicity AssayLonza White Paper
-
3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay -
Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity AssayProtocol instructions
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cellsA strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
TechSheet - Poietics™ Human Immune System CellsTechnical Product Information Sheet
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.